openPR Logo
Press release

Investigation announced for Investors in Consensus Cloud Solutions, Inc. (NASDAQ: CCSI) over potential Wrongdoing

05-17-2023 08:22 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Shareholders Foundation

An investigation on behalf of investors in Consensus Cloud Solutions, Inc. (NASDAQ: CCSI) shares over potential wrongdoing.

An investigation on behalf of investors in Consensus Cloud Solutions, Inc. (NASDAQ: CCSI) shares over potential wrongdoing.

An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Consensus Cloud Solutions, Inc.

Investors who purchased shares of Consensus Cloud Solutions, Inc. (NASDAQ: CCSI) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm concerns whether certain Consensus Cloud Solutions, Inc. directors breached their fiduciary duties and caused damage to the company and its shareholders.

Los Angeles, CA based Consensus Cloud Solutions, Inc., together with its subsidiaries, provides information delivery services with a software-as-a-service platform worldwide. Consensus Cloud Solutions, Inc. reported that its annual Total Revenue rose from $352.66 million in 2021 to $362.42 million in 2022, and that its Net Income declined from $109 million in 2021 to $72.41 million in 2022.

On February 22, 2023, Consensus Cloud Solutions, Inc. (NASDAQ: CCSI announced that "as a result of the unintentional errors noted [below], the audit committee (the 'Audit Committee') of the board of directors of the Company reached a determination to restate its unaudited financial statements for the three and nine month periods ended September 30, 2022." The "unintentional errors" were "primarily relating to (i) to a legacy accounting practice, inherited from the spin transaction in its SoHo business that grossed up revenue by $1.9 million and $5.3 million for the three and nine month periods ended September 30, 2022, respectively, with a corresponding offset to bad debt expense ('SoHo Error') and (ii) the timing of revenue recognition of $2.2 million and $2.5 million for the three and nine month periods ended September 30, 2022, respectively, which after review, the Company has concluded should be reclassified as deferred revenue ('Deferred Revenue Error')."

Shares of Consensus Cloud Solutions, Inc. (NASDAQ: CCSI) declined from $62.08 per share on February 16, 2023, to $41.89 million on February 24, 2023.

Those who purchased shares of Consensus Cloud Solutions, Inc. (NASDAQ: CCSI) have certain options and should contact the Shareholders Foundation.

Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Investigation announced for Investors in Consensus Cloud Solutions, Inc. (NASDAQ: CCSI) over potential Wrongdoing here

News-ID: 3056357 • Views:

More Releases from Shareholders Foundation

ALERT: Lawsuit filed for Investors who SOLD shares of Sina Corporation (formerly NASDAQ: SINA)
ALERT: Lawsuit filed for Investors who SOLD shares of Sina Corporation (formerly …
An investor, who sold shares of Sina Corporation (formerly NASDAQ: SINA) in the merger between Seina Corporation and TuSimple Holdings, Inc, filed a lawsuit over alleged violations of Federal Securities Laws by Sina Corporation (formerly NASDAQ: SINA in connection with certain allegedly false and misleading statements made. If you sold a significant amount of shares of Sina Corporation (formerly NASDAQ: SINA) between October 13, 2020 and March 22, 2021, you have
Lawsuit Alert: Investors who lost money with shares of Fluor Corporation (NYSE: FLR) should contact the Shareholders Foundation
Lawsuit Alert: Investors who lost money with shares of Fluor Corporation (NYSE: …
An investor, who purchased shares of Fluor Corporation (NYSE: FLR), filed a lawsuit alleged violations of Federal Securities Laws by Fluor Corporation in connection with certain allegedly false and misleading statements. Investors who purchased shares of Fluor Corporation (NYSE: FLR) have certain options and for certain investors are short and strict deadlines running. Deadline: November 14, 2025. NYSE: FLR investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779
Investigation announced for Long-Term Investors in shares of Sable Offshore Corp. (NYSE: SOC)
Investigation announced for Long-Term Investors in shares of Sable Offshore Corp …
An investigation was announced for long-term investors in shares of Sable Offshore Corp. (NYSE: SOC) concerning potential breaches of fiduciary duties by certain directors of Sable Offshore Corp. Investors who are current long term investors in Sable Offshore Corp. (NYSE: SOC) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term investors in
Lawsuit filed for Investors who lost money with shares of Lantheus Holdings, Inc. (NASDAQ: LNTH)
Lawsuit filed for Investors who lost money with shares of Lantheus Holdings, Inc …
An investor, who purchased shares of Lantheus Holdings, Inc. (NASDAQ: LNTH), filed a lawsuit over alleged violations of Federal Securities Laws by Lantheus Holdings, Inc. in connection with certain allegedly false and misleading statements. Investors who purchased shares of Lantheus Holdings, Inc. (NASDAQ: LNTH) have certain options and for certain investors are short and strict deadlines running. Deadline: November 10, 2025. NASDAQ: LNTH investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com

All 5 Releases


More Releases for Consensus

Pinnacle of Glory, Global Consensus Ignited: SMiC Mount Fuji Partner Program Str …
This is an exhilarating moment! SMiC is declaring with unstoppable momentum that the new era of global DAO has officially begun! As a benchmark for global DAO, our mission is to lead global partners to the pinnacle of wealth, and our vision is to surpass Bitcoin in consensus of digital credentials! Now, the SMiC Mount Fuji Partner Program is about to launch, and this unprecedented event will ignite the passion
BlockDAG: Revolutionizing Digital Consensus with Eco-Conscious Efficiency
Image: https://www.abnewswire.com/uploads/7c36a582da6df7df428a05159a99dadc.jpg In an era where digital transformation and environmental sustainability are paramount, BlockDAG emerges as a groundbreaking proof-of-work consensus mechanism that promises to redefine the cryptosphere. Leveraging a Directed Acyclic Graph (DAG) structure, BlockDAG is designed to deliver unparalleled speed, security, and efficiency, setting a new standard for digital transactions. Innovative Architecture BlockDAG's architecture distinguishes itself from traditional blockchain technologies through its innovative Directed Acyclic Graph structure. This design prioritizes eco-conscious practices
Analysts Consensus Reaffirms Significant Upside Potential for Cardiol Therapeuti …
According to Gantoss, Cardiol Therapeutics (NASDAQ:CRDL) (TSX:CRDL) has many things going in its favor right now heading into a critical Phase 2 trial readout in RP in June that he believes will lead to a positive outcome. Cardiol Therapeutics (NASDAQ:CRDL) (TSX:CRDL), a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease, has been attracting substantial interest from investors
SecuX to Host Blockchain Security Event at Consensus 2024
You're Invited: Safeguarding the Future - Innovations in Blockchain Security May 23, 2024 Austin, Texas, SecuX, a blockchain security and cryptocurrency hardware wallet company, join us on May 29, 2024, at 3:00 PM at Halcyon, Austin, Texas, for an exclusive side event at the 2024 Consensus conference. "Safeguarding the Future: Innovations in Blockchain Security" brings together industry leaders and experts to explore the latest trends and innovations in blockchain security. Engage with
Tacans Labs Set To Launch Two Revolutionary DEXes During Consensus 2023
Tacans Labs, the DeFi venture builder arm of Tacans, is proud to announce the upcoming launch of two of its key decentralized trading platforms during Consensus 2023, which is set to be held in Austin, Texas, between the 26th and 28th of April. Building Scalable Infrastructure That Will Enhance The DeFi Experience Tacans was founded in 2021 and has assembled a team of industry veterans to lead the development of its platforms.
COVID-19 Impact on Sanofi Report- SWOT Analysis and Global Analyst Consensus Sal …
Sanofi is a leader in developing vaccines for infectious diseases, and it has 73 manufacturing sites located in 32 countries. It's portfolio that includes vaccines for polio, pertusis, Haemophilus influenzae type B, influenza, and meningitis, as well as travel vaccines. Sanofi's COVID-19 response includes sarilumab, recombinant and mRNA vaccines. Single User License: US $ 495 Purchase this Report @ https://www.marketreportsonline.com/contacts/purchase.php?name=816182 Scope of Sanofi Report- - This report gives an important expert analysis on how